TFS Capital’s Audentes Therapeutics BOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding BOLD
TFS Capital's BOLD Position: Q3 2017 in Review
TFS Capital sold out of Audentes Therapeutics (BOLD) in Q3 2017, closing a stake of 10,587 shares — an estimated $203K sold.
TFS Capital first reported a position in BOLD in Q2 2017 and held it in 1 quarter. The position peaked at $203K in Q2 2017. 81 funds tracked by Wall St. Rank hold BOLD as of Q3 2017.
- TFS Capital reported no remaining Audentes Therapeutics position as of Q3 2017 after selling out during the quarter.
- TFS Capital sold 10,587 Audentes Therapeutics shares in Q3 2017, an estimated $203K.
- TFS Capital first reported a position in Audentes Therapeutics in Q2 2017 and held it in 1 quarter.
- TFS Capital's Audentes Therapeutics position peaked at $203K in Q2 2017.
- 81 funds tracked by Wall St. Rank held Audentes Therapeutics as of Q3 2017.
Based on TFS Capital's 13F filing for Q3 2017.